Overcoming drug target alteration often involves combination therapies that target multiple pathways or mechanisms within the cancer cell. For instance, combining immunotherapy with targeted drugs can enhance the treatment's efficacy. Additionally, next-generation sequencing and other advanced diagnostic tools can help identify specific mutations, allowing for more personalized treatment plans.
